首页> 外文OA文献 >Excimer Laser Surgery for the Correction of Myopia(Symposia 'Surgical Treatment for myopia : present status and indications')
【2h】

Excimer Laser Surgery for the Correction of Myopia(Symposia 'Surgical Treatment for myopia : present status and indications')

机译:准分子激光手术矫正近视(专题讨论会“近视的外科治疗:现状和适应症”)

摘要

The number of excimer surgeries for the correction of myopia increased dramatically in the past 5 years. It counts 1.5 million cases in US per year. After the introduction of laser in situ keratomileusis (LASIK), the numbers of excimer laser surgeries in Japan also increased and considered to be 30,000 cases a year. With the advancement of laser itself and surgical techniques, the surgery became safe and effective. However there are some limitations. High myopia, high astigmatism and thin cornea are the major problems. For those patients, new alternative method such as phakic IOL and intracorneal ring (ICR) have been developed. In this symposium, I will cover the indication and results of LASIK as well as the outcome of recent alternative techniques.
机译:在过去的5年中,用于矫正近视的准分子手术数量急剧增加。每年在美国有150万例。引入激光原位角膜磨镶术(LASIK)后,日本的准分子激光手术数量也有所增加,被认为是每年30,000例。随着激光本身和手术技术的发展,手术变得安全有效。但是,有一些限制。高度近视,高度散光和角膜稀薄是主要问题。对于那些患者,已经开发了新的替代方法,例如有晶状体人工晶体和角膜内环(ICR)。在本次研讨会上,我将介绍LASIK的适应症和结果以及最新替代技术的成果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号